Helicobacter pylori increases the risk of peptic ulcer bleeding: A case-control study

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 2, 1999, Pages 110-115

  Labenz, J ^a  

^a Ev Jung Stilling Krankenhaus   (Germany)

Author keywords

Helicobacter pylori; Non steroidal anti inflammatory drugs; Peptic ulcer bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DRUG USE; DUODENUM BLEEDING; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PEPTIC ULCER; PROSPECTIVE STUDY; RISK; SMOKING HABIT; STOMACH HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032945130     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Kreiss C, Slum AL, Malfertheiner P. Peptic ulcer pathogenesis. Curr Opin Gastroenterol 1995;11(Suppl.l):25-31.
2. Lin SK, Lambert JR. Helicobacter pylori in ulcerogenesis. Scand J Gastroenterol 1995;30 (Suppl.2)10:64-9.
3. Nomura A, Stemmerman GN, Chyou PH, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulcération. Ann Intern Med 1994;120:977-81.
4. Lam SK, Ching CK, Lai KC, Wong BCY, Lai CL, Chan CK, et al. Does treatment of Helicobacter pylori (Hp) with antibiotics alone heal duodenal ulcer (DU)? arandomised double-blind placebo-controlled study. Gastroenterology 1996;110:A169.
5. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-52.
6. Tytgat GNJ. Review article. Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
7. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
8. Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994;55:19-23.
9. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J 1990;300:278-84.
10. Hollander D. Gastrointestinal complications of nonsteroidal antiinflammatory drugs: prophylactic and therapeutic strategies. Am J Med 1994;96:274-80.
11. Willett LR, Carson JL, Strom BL. Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs. Drug Safety 1994;10:170-81.
12. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
13. Laine L. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa. Gastroenterol Clin North Am 1993:22:117-25.
14. Taha AS, Russell RI. Helicobacter pylori and non-steroidal antiinflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut 1993:34:580-3.
15. Labenz J, Stolte M, Aygen S, Hennemann O, Bertrams J, Börsch G. Qualitative und semiquantitative invasive und nicht-invasive
16. iagnostik der Helicobacter pylori-Infektion der gastralen Mukosa. Z Gastroenterol 1993;31:437-43.
17. Labenz J, Börsch G, Peitz U, Aygen S, Hennemann O, Tillenburg B, et al. Validity of a novel biopsy urease test (HUT) and a simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis. Digestion 1996;57:391-7.
18. Hosmer D, Lemeshow S. Applied logistic regression. New York: Wiley & Sons, 1989.
19. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Ass 1994;272:65-9.
20. Soil AH. Consensus Statement. Medical treatment of peptic ulcer disease. Practical guidelines. J Am Med Ass 1996;275:622-9.
21. Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995;41:5-7.
22. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the posssibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995;41:l-4.
23. Riemann JF, Schilling D, Schauwecker P, Wehlen G, Dorlars D, Kohler B, et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc 1997;46:299-304.
24. Santander C, Grävalos RG, Gomez-Cedenilla A, Cantero J, Pajares JM. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion therapy in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Am J Gastroenterol 1996;91:1549-52.
25. Al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy 1996;28:229-33.
26. Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9 (Suppl.2):59-64.
27. Henriksson AE, Edman AC, Held M, Wadström T. Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol 1995;7:769-71.
28. Hosking SW, Ling TKW, Yung MY, Cheng A, Chung SCS, Leung JWC, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992;305:502-4.
29. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992;103:862-9.
30. McColl KEL, El-Nujumi AM, Chittajallu RS, Dahill SW, Dorrian CA, EI-Omar E, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993;34:762-8.
31. Lanas AI, Remacha B, Esteva F, Sàinz R. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995;109:1124-33.
32. Hawkey CJ. Review article: aspirin and gastrointestinal bleeding. Aliment Pharmacol Ther 1994:8:141-6.
33. Holvoet J, Terrier L, Van Hee W, Verbist L, Fierens E, Hautekeete ML. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991;32:730-4.
34. Stalnikowicz-Darvasi R. Gastrointestinal bleeding during lowdose aspirin administration for prevention of arterial occlusive events. A critical analysis. J Clin Gastroenterol 1995:21:13-6.
35. The SALT Collaborative Group: Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991:338:1345-9.
36. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Mur-phy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995;310:827-30.
37. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:748-51.
38. Laine L, Cominelli F, Sloane R, Casini-Raggi V, Marin-Sorensen M. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled doubleblind trial. Aliment Pharmacol Ther 1995;9:127-35.
39. Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut 1996;39:22-6.
40. Goggin PM, Collins DA, Jazrawi RP, Jackson PA, Corbishley CM, Bourke BE, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 1993 ;34:1677-80.
41. Graham DY, Lidsky MD, Cox A, Evans Jr DJ, Evans DG, Sessoms SL, et al. Helicobacter pylori infection, NSAIDs, and the gastroduodenal mucosa. Gastroenterology 1990;98:A52.
42. Heresbach D, Raoul JL, Bretagne JF, Minet J, Donio PY, Ramee MP, et al. Helicobacter pylori: a risk and severity factor of nonsteroidal anti-inflammatory drug induced gastropathy. Gut 1992;33:1608-11.
43. Jones ST, Clague RB, Eldridge J, Jones DM. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal antiinflammatory drug (NSAID) treatment in rheumatoid arthritis. Br J Rheumatol 1991;30:16-20.
44. Kim JG, Graham DY. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994;89:203-7.
45. Laìne L, Marin-Sorensen M, Weinstein WM. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development. Am J Gastroenterol 1992;87:1398-402.
46. Lanza FL, Evans DG, Graham DY. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosa] injury after the acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol 1991:86:735-7.
47. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WDW. Influence of Helicobacter pylori on gastric mucosal adaption to naproxen in man. Dig Dis Sei 1996;41:1583-8.
48. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992;102:1899-905.
49. Martin MDF, Montgomery CE, Dobek AS, Patrissi GA, Peura CDA. Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol 1989;84:1268-72.
50. Maxton DG, Srivastava ED, Whorhell PJ, Jones DM. Do nonsteroidal anti-inflammatory drugs or smoking predispose to Helicobacter pylori infection? Postgrad Med J 1990;66:717-9.
51. Publig W, Wustinger C, Zandl C. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers. Wien Klin Wochenschr 1994:106:276-9.
52. Rabassa AA, Goodgame R, Sutton FM, Ou CN, Rognerud C, Graham DY. Effects of aspirin and Helicobacter pylori on the gastroduodenal permeability to sucrose. Gut 1996;39:159-63.
53. Santucci L, Fiorucci S, Patoia L, Di Matteo FM, Brunori PM, Morelli A. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sei 1995;40:2074-80.
54. Scherak O, Hirschl AM, Nemec H, Amann Bkolarz G, Thumb N. Helicobacter pylori and nonsteroidal antirheumatics. Dtsch Med Wochenschr 1990;115:1171-5.
55. Shallcross TM, Rathbone BJ, Wyatt JI, Heatley RV. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 1990;4:515-22.
56. Taha AS, Angerson W, Nakshabendi I, Beekmann H, Morran C, Sturrock RD et al. Gastric and duodenal mucosa blood flow in patients receiving non-steroidal anti-inflammatory drugs - influence of age, smoking, ulceration and Helicobacter pylori. Aliment Pharmacol Ther 1993;7:41-5.
57. Taha AS, Dahill S, Nakshabendi I, Lee FD, Sturrock RD, Russell RI. Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993;34:1162-6.
58. Taha AS, Sturrock RD, Russell RI. Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut 1995;36:334-6.
59. Taha AS, Sturrock RD, Russell RI. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1992:87:1732-5.
60. Thillainayagam AV, Tabaqchali S, Warrington SJ, Farthing MJG. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. Dig Dis Sei 1994;39:1085-9.
61. Upadhyay R, Howatson A, McKinley A, Danesh BJ, Sturrock RD, Russell RI. Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1988;27:113-6.
62. Chan FKL, Sung-JY, Chung SCS, To KF, Yung MY, Leung VKS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975-9.
63. Cullen DIE, Hawkey GM, Greenwood DC, Cave R, Shepherd V, Logan RFA, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997;41:459-62.
64. Wilcox CM, Alexander LN, Starub RF, Clark WS. A prospective evaluation of the causes of upper GI hemorrhage in alcoholics: a focus on alcoholic gastropathy. Am J Gastroenterol 1996;91:1343-7.
65. Kelly JP, Kaufman DW, Koff RS, Laszlo A, Wiholm BE, Shapiro S. Alcohol consumption and the risk of major upper gastrointestinal bleeding. Am J Gastroenterol 1995 ;90:105 8-64.
66. Hook-Nikanne J. Effect of alcohol consumption on the risk of Helicobacter pylori infection. Digestion 1991:50:92-8.
67. Schubert TT, Bologna SD, Nensey Y, Schubert AB, Mascha EJ, Ma CK. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age. Am J Med 1993;94:413-8.